• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌缺血诊断后的合理管理。

Rational management following diagnosis of myocardial ischemia.

作者信息

Hugenholtz P, Serruys P, Laird-Meeter K, Fioretti P

出版信息

Can J Cardiol. 1986 Jul;Suppl A:242A-247A.

PMID:2875774
Abstract

Assuming one knows that myocardial ischemia is present, rational management will first require a careful history to assess the severity of symptoms, such as angina, the lifestyle of the patient, his/her age, and the availability of resources. When a patient is greater than or equal to 70 years, has little angina, even the demonstration of ischemia will not require early arteriography; pharmacological therapy on a trial basis is the preferred approach. Judging the response to oral nitroglycerine, isosorbide dinitrate, beta blockers and calcium antagonists, (often combined and in modest doses) is good rational management. If symptoms persist despite therapy or when the patient is younger and has symptoms which cannot be alleviated by changes in lifestyle and/or workload, the established ischemia assumes much greater significance and nearly always requires a coronary arteriogram for proper management. Once the coronary arteriogram has been analyzed in terms of severity of flow impairment, correlation with the tests showing the extent of myocardial ischemia must be made, best during exercise. If single vessel disease is found with a local dyskinetic (echo, scintigraphy, or angio) segment, which corresponds to a stenosis of greater than or equal to 70%, particularly when found in the anterior descending artery, balloon dilatation (PTCA) or bypass surgery (CABG) should follow. When tests, such as the ECG, are obtained during an attack of angina, the Chahine classification may be used first. In Class IIa with pure ST-segment elevation significant atherosclerotic lesions are absent in most patients, while local spasm can be shown upon provocation. Here rational management can be limited to calcium antagonists sometimes combined with beta blockers.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

假设已知存在心肌缺血,合理的治疗首先需要详细了解病史,以评估症状的严重程度,如心绞痛情况、患者的生活方式、年龄以及可利用的资源。当患者年龄大于或等于70岁且心绞痛症状较轻时,即使证实存在缺血,也无需早期进行动脉造影;试验性药物治疗是首选方法。判断患者对口服硝酸甘油、二硝酸异山梨酯、β受体阻滞剂和钙拮抗剂(通常联合使用且剂量适中)的反应是合理的治疗措施。如果尽管进行了治疗症状仍持续存在,或者患者较年轻且症状无法通过改变生活方式和/或工作量得到缓解,已确诊的缺血就具有更大的意义,几乎总是需要进行冠状动脉造影以进行恰当治疗。一旦根据血流受损的严重程度分析了冠状动脉造影结果,就必须将其与显示心肌缺血范围的检查结果进行关联,最好是在运动期间。如果发现单支血管病变伴有局部运动障碍(超声心动图、闪烁扫描或血管造影显示)节段,且该节段对应狭窄大于或等于70%,特别是在前降支动脉发现时,应随后进行球囊扩张术(PTCA)或搭桥手术(CABG)。当在心绞痛发作期间进行如心电图等检查时,可首先使用查希内分类法。在IIa类中,大多数患者不存在明显的动脉粥样硬化病变,仅有单纯ST段抬高,而激发试验时可显示局部痉挛。在此情况下,合理的治疗可限于有时联合β受体阻滞剂使用的钙拮抗剂。(摘要截选至250字)

相似文献

1
Rational management following diagnosis of myocardial ischemia.心肌缺血诊断后的合理管理。
Can J Cardiol. 1986 Jul;Suppl A:242A-247A.
2
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
3
Comprehensive drug management of angina pectoris.心绞痛的综合药物治疗
Cardiovasc Clin. 1984;14(3):139-51.
4
[Therapeutic possibilities, respective implications in silent ischemia].[治疗可能性及其在无症状性缺血中的各自影响]
Z Kardiol. 1992 Apr;81(4):193-8.
5
[Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].[急性心肌梗死后的治疗措施:经皮冠状动脉腔内血管成形术(PTCA)、手术及药物的差异应用]
Schweiz Med Wochenschr. 1996 Feb 3;126(5):164-76.
6
Stable angina as a manifestation of ischemic heart disease: medical management.
Circulation. 1985 Dec;72(6 Pt 2):V145-54.
7
[Therapy of silent ischemia].[无症状性心肌缺血的治疗]
Acta Med Austriaca. 1992;19(3):70-3.
8
Silent myocardial ischemia. Rationale for management.无症状性心肌缺血。治疗原理。
Postgrad Med. 1988 Feb 29;Spec No:76-82.
9
What is optimal drug therapy in angina pectoris?
Cardiovasc Clin. 1983;13(1):209-20.
10
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.药物、血管成形术或手术研究(MASS II)的五年随访:一项针对多支冠状动脉疾病三种治疗策略的随机对照临床试验
Circulation. 2007 Mar 6;115(9):1082-9. doi: 10.1161/CIRCULATIONAHA.106.625475.